Drug Summary
Drug name: dantrolene Chemical name: Dantrolene sodium salt Formula: C14H10N4O5 Weight: 314.253 CAS no: 7261-97-4 DrugBank link: DB01219 Description: Chemically, dantrolene is a hydantoin derivative, but does not exhibit antiepileptic activity like other hydantoin derivates such as phenytoin. Indication: For use, along with appropriate supportive measures, for the management of the fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crises in patients of all ages. Also used preoperatively, and sometimes postoperatively, to prevent or attenuate the development of clinical and laboratory signs of malignant hyperthermia in individuals judged to be malignant hyperthermia susceptible.